Form 4 · Filed Jun 3, 2026, 09:30 PM UTC
CUE/Cue Biopharma, Inc.
Lin Shao-Lee — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | P | buy | 90,906 | — | — | 90,906 |
| Jun 1, 2026 | P | buy | 45,453 | — | — | 45,453 |
Source: SEC EDGAR raw filing ↗ · Accession 0001725092-26-000004